The regulation of CD4 and CD8 coreceptor gene expression during T cell development. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The regulation of CD4 and CD8 coreceptor gene expression during T cell development.

Unique Identifier : AIDSLINE MED/99286819
Ellmeier W; Sawada S; Littman DR; Molecular Pathogenesis Program, Skirball Institute of; Biomolecular Medicine, New York, NY 10016, USA.


Abstract: The two major subsets of T lymphocytes in the peripheral immune system, the helper and cytotoxic T cells, are defined by their expression of either the CD4 or the CD8 glycoproteins, respectively. Expression of these molecules, which serve as coreceptors by interacting specifically with either MHC class II or class I molecules, also defines discrete stages of T cell development within the thymus. Thus, CD4+ and CD8+ single-positive (SP) thymocytes arise from common progenitor double positive (DP) cells that express both CD4 and CD8, during a process known as positive selection. The molecular mechanisms underlying the developmental choice toward the helper or cytotoxic lineage remain poorly understood. Because regulation of coreceptor gene expression appears to be coupled to the phenotypic choice of the differentiating T cell, it is likely that shared signaling pathways direct CD4 and CD8 transcription and the development of an uncommited DP thymocyte toward either the helper or cytotoxic lineage. Therefore, an understanding of how CD4 and CD8 expression is regulated will not only provide insights into transcriptional control mechanisms in T cells, but may also result in the identification of molecular factors that are involved in lineage choices during T cell development. In this review, we summarize recent progress that has been made toward an understanding of how CD4 and CD8 gene expression is regulated.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC Animal Antigens, CD4/*GENETICS Antigens, CD8/*GENETICS Cell Differentiation CD4-Positive T-Lymphocytes/CYTOLOGY/IMMUNOLOGY CD8-Positive T-Lymphocytes/CYTOLOGY/IMMUNOLOGY Enhancer Elements (Genetics) Gene Expression Regulation, Developmental Human Mice Models, BiologicalKWDjournalarticlereviewreview,academicanimalantigens,cd4/KWDgeneticsantigens,cd8/KWDgeneticscelldifferentiationcd4-positivet-lymphocytes/cytology/immunologycd8-positivet-lymphocytes/cytology/immunologyenhancerelements(genetics)geneexpressionregulation,developmentalhumanmicemodels,biological
991130
A99B1095

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .